
February 25, 2019 Sales and Marketing Clementia pharmaceuticals, acquisition, ipsen, rare disease

February 25, 2019 Sales and Marketing Home office, UK, cocaine, drugs, fentanyl, illicit substances, recreational drugs

February 25, 2019 Sales and Marketing Cancer, J&J, JJ, asbestos, baby powder, lawsuits, legal, talc

February 25, 2019 Sales and Marketing Roche, Spark Therapeutics, acquisition, gene therapy, pharma

February 25, 2019 Sales and Marketing FDA, Iran, Venezuela, biotech, global, pharma

February 22, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

February 21, 2019 Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior

February 21, 2019 Business Services, Sales and Marketing FTC, Teva, antitrust, drugs, generics, monopoly

February 19, 2019 Manufacturing and Production, Sales and Marketing Philippines, Sanofi, dengue, dengvaxia, pharma

February 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus

February 18, 2019 Research and Development, Sales and Marketing Astellas, Cancer, Xtandi, pharma, prostate cancer

February 18, 2019 Sales and Marketing Cancer, cancer research, immune system, immunology, melanoma, oncology, smoking

February 18, 2019 Research and Development, Sales and Marketing Bavencio, Cancer, Kidney cancer, Merck KGaA, Pfizer, inlyta, pharma

February 18, 2019 Sales and Marketing SIRT1, depression, genetics, mental health

February 18, 2019 Sales and Marketing Cancer, MSD, Merck Sutent, Pfizer, inlyta, keytruda, oncology, rcc, renal cell carcinoma